DSpace Repository
The effectiveness of anticoagulant therapy in Covid-19 associated ischemic stroke
- DSpace Home
- →
- Tashkent Medical Academy Library
- →
- Thesis, Articles
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Khamidov, Abdulakhad | |
| dc.date.accessioned | 2022-11-11T17:42:14Z | |
| dc.date.available | 2022-11-11T17:42:14Z | |
| dc.date.issued | 2022 | |
| dc.identifier.issn | 2181-3485 | |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/4539 | |
| dc.description.abstract | This article analyzes the effects and efficacy of various anticoagulant agents on hemorheological indicators used in Covid-19 associated ischemic stroke and post treatment results in the early stages of the disease are presented | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Ташкент | en_US |
| dc.subject | Covid-19, SARS-CoV-2, ischemic stroke, activated partial thromboplastin time, D-dimer, fibrinogen, prothrombin time, heparin, enoxiparin, rivaroxaban | en_US |
| dc.title | The effectiveness of anticoagulant therapy in Covid-19 associated ischemic stroke | en_US |
| dc.type | Article | en_US |
Files in this item
This item appears in the following Collection(s)
-
Thesis, Articles [10346]